Sysmex (OTCMKTS:SSMXY) Hits New 52-Week Low – Here’s What Happened

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $8.15 and last traded at $8.49, with a volume of 10282 shares. The stock had previously closed at $9.42.

Sysmex Price Performance

The stock has a 50-day moving average price of $9.72 and a two-hundred day moving average price of $11.29. The company has a current ratio of 3.34, a quick ratio of 2.49 and a debt-to-equity ratio of 0.11. The stock has a market cap of $5.36 billion, a price-to-earnings ratio of 17.75 and a beta of 1.14.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings results on Thursday, February 12th. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.01. Sysmex had a return on equity of 9.32% and a net margin of 8.86%.The company had revenue of $837.32 million during the quarter, compared to analysts’ expectations of $819.99 million. As a group, equities research analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current year.

Sysmex Company Profile

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.